根据紧急使用授权授权的处方药的宣传材料的内容分析
Bridget Kelly1, Kathryn J Aikin2, Helen W Sullivan2
1RTI International, 3040 Cornwallis Rd., Durham, NC, 27709, USA. bkelly@rti.org.
Drug safety
|September 25, 2025
概括
具有紧急使用授权 (EUA) 的药物的促销材料往往缺乏明确的 EUA 定义,并在研究生阅读水平上提供消费者信息. 为了让公众更好地理解,需要提高清晰度和可读性.
科学领域:
- 药品营销 药品营销 药品营销
- 监管科学 监管科学
- 卫生沟通健康沟通
背景情况:
- 美国FDA可以为未经批准的产品或在公共卫生紧急情况下的用途颁发紧急使用授权 (EUA).
- 虽然允许推广 EUA 产品,但使用的沟通策略尚不清楚.
研究的目的:
- 分析针对医疗保健提供者和消费者的宣传材料中如何描述紧急使用授权 (EUA).
- 为了确定不同受众的材料之间的促销内容和可读性之间的差异.
主要方法:
- 提交给FDA的423份美国药物统计局药品宣传材料的内容分析 (2020年4月-2023年4月).
- 与 EUA 相关的术语和风险信息的存在/缺失和位置的编码.
- 统计和可读性分析,比较消费者和HCP材料.
主要成果:
- 大多数材料包括风险信息,但很少有人定义"EUA".
- 高CP材料更有可能与 EUA 资源联系起来.
- 消费者材料表现出非常困难的阅读水平,需要研究生水平的理解能力.
结论:
- 关于 EUA 产品的宣传材料应包括"EUA"的明确定义,并强调消费者的限制.
- 使用简单语言原则提高面向消费者的材料的可读性至关重要.
- 有针对性的改进可以提高不同受众对 EUA 产品的理解.
更多相关视频
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
14.8K
10:13Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
2.8K
相关概念视频
Prescription, Nonprescription and Orphan Drugs
1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Drug Classes and Categories
3.0K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
3.0K
Drug Nomenclature
3.2K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
3.2K
FDA Approved Drugs: Changes to Approved Drugs
244
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
244
